Seelos Therapeutics Inc (SEEL)
Market Closed
18 Nov, 20:00
OTC PINK OTC PINK Primary $
0. 37
+0.37
+73,899.997%
$
214.97K Market Cap
- P/E Ratio
- Div Yield
350 Volume
-4.09 Eps
$ 0
Previous Close Investors:
Want to track SEEL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 9.6 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 9 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
SEEL Earnings Reports FAQ
What is the earnings per share (EPS) for SEEL?
The current EPS is -4.09.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately 3.28%, reflecting the SEEL's performance and OTC PINK market conditions.
When is the next earnings release date?
Seelos Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Seelos Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for SEEL at this time, as Seelos Therapeutics Inc has no recent EPS data to calculate it.
